Our products comprise the medication needed to relieve symptoms and significantly improve the quality of life, as well as medication that is primarily used in critical, life-threatening situations. That is why we maintain constant communication with medical specialists and focus on the real needs in medical practice to develop products in line with actual clinical requirements.
Highest quality standards, delivery reliability and a strong drive to excel as a team are fundamentally important to us. We act swiftly and flexibly to find the right solutions – in close consultation with medical specialists and for the benefit of patients. We share the responsibility for the smooth functioning of medical measures at the decisive moment. Whether owner or team members - at AMOMED Pharma, we are fully aware of the importance of our actions and are deeply committed to the far-reaching aspect of our work.
CytoSorbents is a critical care immunotherapy company commercializing its CE approved CytoSorb, a safe and effective cytokine adsorber. CytoSorb is designed to attenuate the dysregulated, hyperinflammatory response („cytokine storm“) present in septic shock and other, non-infectious systemic hyperinflammatory states by reducing elevated levels of cytokines and other inflammatory mediators. This modulation of the immune response can lead to an improvement of hemodynamics, a reduction in the need for vasopressors and overall to an increased chance for recovery of organ functions and improved patient outcomes. CytoSorb is indicated in various hyperinflammatory states of infectious and non-infectious origin, e.g. after cardiac surgery, in cardiogenic shock, trauma, burns, pancreatitis and infection. So far it has been used safely and well tolerated in more than 27,000 single treatments worldwide. CytoSorb Therapy – REGAIN CONTROL!